Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease
Open Access
- 17 June 2021
- journal article
- research article
- Published by European Respiratory Society (ERS) in ERJ Open Research
Abstract
In COPD, anaemia is associated with increased morbidity, but the relationship between haemoglobin over its entire observed range and morbidity is poorly understood. Such an understanding could guide future therapeutic targeting of haemoglobin in COPD management. Leveraging the COPDGene study, we conducted a cross-sectional analysis of haemoglobin from COPD participants, examining symptoms, quality of life, functional performance, and acute exacerbations of COPD (AECOPD). Haemoglobin was analysed both as a continuous variable and categorised into anaemia, normal haemoglobin, and polycythaemia groups. Fractional polynomial modelling was used for continuous analyses; categorical models were multivariable linear or negative binomial regressions. Covariates included demographics, comorbidities, emphysema, diffusing capacity, and airflow obstruction. From 2539 participants, 366 (14%) were identified as anaemic and 125 (5%) as polycythaemic. Compared with normal haemoglobin, anaemia was significantly associated with increased symptoms (COPD Assessment Test score: p=0.006, modified Medical Research Council (mMRC) Dyspnoea Score: p=0.001); worse quality of life (St. George's Respiratory Questionnaire (SGRQ) score: p<0.001; Medical Outcomes Study Short Form 36-item Questionnaire (SF-36) General Health: p=0.002; SF-36 Physical Health: p<0.001), decreased functional performance (6-min walk distance (6MWD): p<0.001), and severe AECOPD (p=0.01), while polycythaemia was not. Continuous models, however, demonstrated increased morbidity at both ends of the haemoglobin distribution (p<0.01 for mMRC, SGRQ, SF-36 Physical Health, 6MWD, and severe AECOPD). Evaluating interactions, both diffusing capacity and haemoglobin were independently associated with morbidity. We present novel findings that haemoglobin derangements towards either extreme of the observed range are associated with increased morbidity in COPD. Further investigation is necessary to determine whether haemoglobin derangement drives morbidity or merely reflects systemic inflammation, and whether correcting haemoglobin towards the normal range improves morbidity.Keywords
Funding Information
- COPD Foundation
- National Heart, Lung, and Blood Institute (U01 HL089856, U01 HL089897)
This publication has 48 references indexed in Scilit:
- Hepcidin: A useful marker in chronic obstructive pulmonary diseaseAnnals of Thoracic Medicine, 2012
- Chronic Obstructive Pulmonary Disease Exacerbations in the COPDGene Study: Associated Radiologic PhenotypesRadiology, 2011
- The minimal important difference of exercise tests in severe COPDEuropean Respiratory Journal, 2010
- Genetic Epidemiology of COPD (COPDGene) Study DesignCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2010
- Updating the Minimal Important Difference for Six-Minute Walk Distance in Patients With Chronic Obstructive Pulmonary DiseaseArchives of Physical Medicine and Rehabilitation, 2010
- Patient-Reported Dyspnea in COPD Reliability and Association With Stage of DiseaseSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2009
- Development and first validation of the COPD Assessment TestEuropean Respiratory Journal, 2009
- Anemia in chronic obstructive pulmonary disease: epidemiology and economic implicationsCurrent Medical Research and Opinion, 2008
- LONG TERM DOMICILIARY OXYGEN THERAPY IN CHRONIC HYPOXIC COR PULMONALE COMPLICATING CHRONIC BRONCHITIS AND EMPHYSEMA: Report of the Medical Research Council Working PartyThe Lancet, 1981
- Smokers' PolycythemiaThe New England Journal of Medicine, 1978